期刊文献+

尖锐湿疣组织中MMP-9的表达及意义

Expression and significance of MMP-9 in condyloma acuminatum tissues
下载PDF
导出
摘要 目的:研究尖锐湿疣组织中MMP-9的表达及与CD105标染的疣体内微血管密度(MVD)和瘤体生物学行为的相关性。方法:运用免疫组化SP法检测MMP-9在35例尖锐湿疣组织、15例正常包皮组织中的表达及CD105标染的新生血管的密度,分析MMP-9在尖锐湿疣组织中的表达情况,进一步分析其表达与MVD值、临床病理特征及复发的关系。结果:MMP-9在尖锐湿疣组的表达水平明显高于正常包皮组(P<0.01),尖锐湿疣组的MVD值高于正常包皮组(P<0.01)。Spearman相关分析提示MMP-9表达水平与MVD值呈正相关。结论:MMP-9过表达可能与尖锐湿疣疣体的形成和频繁复发有关,MMP-9蛋白过度表达在尖锐湿疣疣体的血管形成中具有重要的临床意义。 Objective: To study the expression of MMP-9 in condyloma aeuminatum (CA) tissues and detect the correlation between CD105 stained MVD and the biological behaviors of the disease. Methods: The expression of CD105 and MMP-9 in 35 cases of CA and 15 cases of prepuces was studied by SP immunohistochemical method. The correlation between their expression levels and clinical pathological features was also analyzed. Results: The expression of MMP-9 in CA tissues was higher compared with normal prepuces (P〈0.01). MVD in CA group was higher than the normal prepuces (P〈0.01). Spearman correlation analysis suggested that the expression of MMP-9 was positively correlated with MVD. Conclusion: The overexpression of MMP-9 may be related to the occurrence and frequent recurrence of CA, and the overexpression of MMP-9 plays a key role in the angiogenesis of CA.
出处 《中国医药导报》 CAS 2009年第19期19-20,共2页 China Medical Herald
关键词 尖锐湿疣 MMP-9 CD105 微血管密度 免疫组织化学 Condyloma acuminatum MMP-9 CD105 MVD Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献22

  • 1夏克栋,陈向敏,林巧爱,董海艳,张丽芳.热休克蛋白在尖锐湿疣组织中的检测及其与HPV感染相关性[J].中国皮肤性病学杂志,2005,19(1):12-13. 被引量:2
  • 2王俐,邹金波,骆建民.CD105和Flk1在尖锐湿疣组织中的表达[J].华西医学,2006,21(3):451-452. 被引量:1
  • 3孙澜,陆建云,华纲,陆正中,赵斌斌,冯一中.CD105和p63在尖锐湿疣皮损中的表达及临床意义[J].中华皮肤科杂志,2006,39(11):663-663. 被引量:2
  • 4Begem G, Brekken R, McMahon G, et al. Marx metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J].Nature Cell Biology,2000,2(10):737—744.
  • 5Shimizu M,Saitoh Y,hoh H.Immunohistochemical staining of Ha-ras oncogene product in normal,benign and malignant human pancreatic tissues[J].Hum Pathol,1990,21(6):607—612.
  • 6Kugler A.Matrix metalloproteinases and their inhibitors[J].Anticancer Res,1999.19(2c):1589—1592.
  • 7Nelson AR,Fingleton B,Rothenberg ML,et al.Matrix metalloproteinases:biologic activity and clinical implications [J].Journal of Clinical Oncology,2000,18(5):1135—1149.
  • 8Kurizaki T, Toi M, Tominaga T. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma [ J ]. Oncol Rep, 1998, 5 (3): 673-677.
  • 9Tolnay E, Wiethege T, Kuhned C, et al. Expression of type Ⅳ collagenase correlate with the expression of vascular endothelial growth factor in primary non-small cell lung cancer [J]. J Cancer Res Clin Oncol, 1997, 123(11-12): 652-658.
  • 10Riedel F, Gotte K, Schwalb J, et al. Expression of 92-kDa type Ⅳ collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma [J]. Int J Oncol, 2000, 17(6): 1099-1105.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部